Andrew Tan Mulligan is a skilled Bioprocess Engineer currently employed at KalvoTech since February 2024, focusing on the implementation of biomaterials in various bioprocess applications. Previously, Andrew worked at Ivy Farm Technologies, where significant contributions included developing a high-density bioreactor platform and managing complex design and process engineering challenges, resulting in two patent applications. Experience also includes a role as a Scientist at Cignpost Diagnostics Ltd., providing large-scale Covid testing, and lab management in a BSL-2 environment. Andrew's educational background includes a Master of Science in Biomedical Engineering from Imperial College London and a Bachelor of Engineering in Acoustical Engineering from the University of Southampton, complemented by significant projects involving biomedical signal processing and innovative acoustic wave technologies for cell isolation. Early career experience as an Assistant Engineer at Sandy Brown Associates involved complex engineering solutions and technical report drafting.